References
- Bundesamt für Statistik, Sektion Demografie und Migration. Statistik des jährlichen Bevölkerungsstandes (ESPOP) 2007. http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.Document.111689.pdf. Accessed October 25, 2010.
- National Institute for Cancer Epidemiology and Registration (NICER). Switzerland: Statistics of cancer incidence 1983–2007, April 2010. http://asrt.ch/nicer/stat/i5ch8307.pdf. Accessed October 25, 2010.
- Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the northeastern United States. Scand J Urol Nephrol 2008;42:237–42.
- Engeler DS, Wyler S, Neyer M, Hobi C, Müller J, Schmid HP.Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases. Scand J Urol Nephrol 2008;42:522–7.
- Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303–14.
- Bittorf B, Kessler H, Merkel S, Brückl W, Wein A, Ballhausen WG, Multiple primary malignancies: an epidemiological and pedigree analysis of 57 patients with at least three tumours. Eur J Surg Oncol 2001;27:302–13.
- Jensen OM, Knudsen JB, Sorensen BL. Second cancer following cancer of the urinary system in Denmark, 1943--80. Natl Cancer Inst Monogr 1985;68:349–60.
- Klotz T, Hofstadter F, Gerken M. [Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma]. Urologe A 2003;42:1485–90.
- McCredie M, Macfarlane GJ, Stewart J, Coates M. Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972–91. Cancer Causes Control 1996;7:337–44.
- Landas S, Silberstein J, Nsouli I, Wang CY, Haas GP. Higher than expected association of clinical prostate and bladder cancers. J Urol 2005;173:1526–29.
- Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435–48.
- Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics with confidence. 2nd ed. Bristol: BMJ Books;2000.
- Warren S, Gates O. Multiple primary malignant tumors – a survey of the literature and a statistical study. Am J Cancer 1932;16:1358–414.
- Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005;45:629–56.
- Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Körner H, Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008;7:2591–600.
- Salminen E, Pukkala E, Teppo L, Pyrhonen S. Subsequent primary cancers following bladder cancer. Eur J Cancer 1994;30A:303–7.
- International Agency for Research on Cancer (IARC). Cancer of the lower urinary tract. In: IARC Monographs on the evaluation of carcinogenic risks to humans (Vol83): Tobacco smoke and involuntary smoking. Lyon: World Health Organization;2004. p 212–38.
- Clavel J, Cordier S, Boccon-Gibod L, Hemon D. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int J Cancer 1989;44:605–10.
- Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 1997;8:229–38.
- Daniell HW. A better prognosis for obese men with prostate cancer. J Urol 1996;155:220–5.
- Furuya Y, Akimoto S, Akakura K, Ito H. Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan. Int J Urol 1998;5:134–7.
- Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 2000;151:541–9.
- Nelson WG, De Marzo AM, DeWeese TL. The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention. Urology 2001;57(Suppl1):39–45.